NIH Seeks to Fund MDx, Biomarker Development for Liver Diseases | GenomeWeb

NEW YORK (GenomeWeb News) — The National Institutes of Health plans to fund small businesses that will develop technologies for advancing the means of diagnosing, treating, and preventing liver disease, including biomarker research, and molecular diagnostics and reagents, among others.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.